Bronchiectasis is a chronic respiratory condition characterised by cough, mucus production and recurrent chest infections.
It can have different origins, with up to half of the people with bronchiectasis not knowing its origin.
Current treatments’ goal is to treat the underlying conditions and lung infections, to remove mucus from the lungs, and to prevent complications. There is a lot of research going on and directed toward breaking the cycle of bronchiectasis with therapies that aim to improve airway clearance, treating chronic infection and reducing inflammation.
This section offers readers more information into this ongoing research work.
Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis
Ciprofloxacin DPI (BAYQ3939)
Human mesenchymal stem cells
Salmeterol-Fluticasone Combined Inhaled Therapy
Bronchiectasis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.